Outcomes and Management of SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation (HCT) and Chimeric Antigen Receptor T cell (CART) therapy
Description
CONCLUSIONS: We observed higher overall survival in HCT and CART recipients infected with the Omicron variants compared to the ancestral strain of SARS-CoV2. Use of COVID-19 antivirals, monoclonal antibodies, and vaccines may have contributed to
